(0.05%) 5 472.28 points
(0.10%) 39 150 points
(0.37%) 17 783 points
(0.01%) $80.84
(-3.66%) $2.66
(-0.80%) $2 312.10
(0.16%) $28.92
(3.51%) $1 021.00
(0.27%) $0.936
(0.69%) $10.68
(0.43%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates...
Stats | |
---|---|
今日成交量 | 527 111 |
平均成交量 | 1.53M |
市值 | 292.44M |
EPS | $-0.0243 ( Q1 | 2024-05-01 ) |
下一个收益日期 | ( $0 ) 2024-07-31 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-5.48 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00200 (0.28%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-20 | Reilly Thomas Charles | Buy | 33 333 | Ordinary Shares |
2024-06-20 | Reilly Thomas Charles | Sell | 16 417 | Ordinary Shares |
2024-06-20 | Reilly Thomas Charles | Sell | 33 333 | Restricted Stock Unit |
2024-04-18 | Cohen Paul | Buy | 179 795 | Stock Option (right to buy) |
2024-04-18 | Cohen Paul | Buy | 50 287 | Restricted Stock Unit |
INSIDER POWER |
---|
87.22 |
Last 98 transactions |
Buy: 13 144 339 | Sell: 747 624 |
音量 相关性
Amarin Corporation PLC 相关性 - 货币/商品
Amarin Corporation PLC 财务报表
Annual | 2023 |
营收: | $308.10M |
毛利润: | $202.59M (65.75 %) |
EPS: | $-0.150 |
FY | 2023 |
营收: | $308.10M |
毛利润: | $202.59M (65.75 %) |
EPS: | $-0.150 |
FY | 2022 |
营收: | $369.19M |
毛利润: | $242.48M (65.68 %) |
EPS: | $-0.260 |
FY | 2021 |
营收: | $583.19M |
毛利润: | $461.86M (79.20 %) |
EPS: | $0.0200 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Amarin Corporation PLC
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。